이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Sonic Healthcare 관리

관리 기준 확인 3/4

Sonic Healthcare's CEO는 Colin Goldschmidt, Jan1993 에 임명되었습니다 의 임기는 31.42 년입니다. 총 연간 보상은 A$ 5.97M, 39.7% 로 구성됩니다. 39.7% 급여 및 60.3% 보너스(회사 주식 및 옵션 포함). 는 A$ 26.38M 가치에 해당하는 회사 주식의 0.21% 직접 소유합니다. 26.38M. 경영진과 이사회의 평균 재임 기간은 각각 27.4 년과 9.7 년입니다.

주요 정보

Colin Goldschmidt

최고 경영자

AU$6.0m

총 보상

CEO 급여 비율	39.7%
CEO 임기	31.4yrs
CEO 소유권	0.2%
경영진 평균 재임 기간	27.4yrs
이사회 평균 재임 기간	9.7yrs

최근 관리 업데이트

Recent updates

CEO 보상 분석

Colin Goldschmidt 의 보수는 Sonic Healthcare 의 수익과 비교하여 어떻게 변경되었나요?
날짜	총 보상	급여	회사 수익
Dec 31 2023	n/a	n/a	AU$505m
Sep 30 2023	n/a	n/a	AU$595m
Jun 30 2023	AU$6m	AU$2m	AU$685m
Mar 31 2023	n/a	n/a	AU$850m
Dec 31 2022	n/a	n/a	AU$1b
Sep 30 2022	n/a	n/a	AU$1b
Jun 30 2022	AU$8m	AU$2m	AU$1b
Mar 31 2022	n/a	n/a	AU$1b
Dec 31 2021	n/a	n/a	AU$1b
Sep 30 2021	n/a	n/a	AU$1b
Jun 30 2021	AU$7m	AU$2m	AU$1b
Mar 31 2021	n/a	n/a	AU$1b
Dec 31 2020	n/a	n/a	AU$951m
Sep 30 2020	n/a	n/a	AU$739m
Jun 30 2020	AU$4m	AU$2m	AU$528m
Mar 31 2020	n/a	n/a	AU$554m
Dec 31 2019	n/a	n/a	AU$581m
Sep 30 2019	n/a	n/a	AU$565m
Jun 30 2019	AU$6m	AU$2m	AU$550m
Mar 31 2019	n/a	n/a	AU$510m
Dec 31 2018	n/a	n/a	AU$470m
Sep 30 2018	n/a	n/a	AU$473m
Jun 30 2018	AU$5m	AU$2m	AU$476m

보상 대 시장: Colin 의 총 보상 ($USD 3.98M )은 Australian 시장( $USD 2.69M ).

보상과 수익: Colin 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.

CEO

Colin Goldschmidt (70 yo)

31.4yrs

테뉴어

AU$5,968,507

보상

Dr. Colin Stephen Goldschmidt, M.B.B.Ch., F.R.C.P.A., F.A.I.C.D. serves as the Chief Executive Officer of Sonic Healthcare Limited since 1993 and has been its Managing Director since 1992. Dr. Goldschmidt...

리더십 팀

이름	위치	테뉴어	보상	소유권
Colin Goldschmidt	CEO, MD & Executive Director	31.4yrs	AU$5.97m	0.21% A$ 26.1m
Christopher Wilks	Finance Director	31.4yrs	AU$2.84m	0.13% A$ 16.5m
Peter Savage	Chief Business Officer	no data	데이터 없음	데이터 없음
Stephen Fairy	Global Chief Medical Officer	no data	데이터 없음	데이터 없음
David Byrne	Chief Executive Officer of The Doctors Laboratory	no data	AU$1.07m	데이터 없음
Paul Alexander	Deputy CFO & Company Secretary	23.4yrs	AU$354.42k	데이터 없음
Julian Adler	Chief Executive Officer of Sonic Imaging	4yrs	데이터 없음	데이터 없음
Prashan Kulasekera	Assistant Company Secretary	no data	데이터 없음	데이터 없음

27.4yrs

평균 재임 기간

65yo

평균 연령

경험이 풍부한 관리: SHL 의 관리팀은 노련하고 경험 (평균 재직 기간 27.4 년)입니다.

이사회 구성원

이름	위치	테뉴어	보상	소유권
Colin Goldschmidt	CEO, MD & Executive Director	31.4yrs	AU$5.97m	0.21% A$ 26.1m
Christopher Wilks	Finance Director	34.5yrs	AU$2.84m	0.13% A$ 16.5m
Kathryn Spargo	Non-Executive Independent Director	13.9yrs	AU$263.00k	0.0054% A$ 683.5k
Christine Bennett	Independent Non-Executive Director	1.8yrs	AU$153.79k	0.0011% A$ 133.9k
Neville Mitchell	Independent Non-Executive Director	6.8yrs	AU$266.00k	0.0020% A$ 256.5k
Mark Compton	Independent Non-Executive Chairman	9.7yrs	AU$550.00k	0.0030% A$ 381.6k
Louis Panaccio	Non-Executive Independent Director	19yrs	AU$262.00k	0.0017% A$ 211.0k
Katharine Giles	Independent Non-Executive Director	1.8yrs	AU$153.79k	0.00052% A$ 65.7k
Suzanne Crowe	Non-Executive Independent Director	4.2yrs	AU$230.80k	0.0015% A$ 189.5k

9.7yrs

평균 재임 기간

67.5yo

평균 연령

경험이 풍부한 이사회: SHL 의 이사회는 경험(평균 재직 기간 9.7 년)으로 간주됩니다.

Sonic Healthcare 관리

관리 기준 확인 3/4

주요 정보

최근 관리 업데이트

Finance Director recently sold AU$1.3m worth of stock

CEO, MD & Executive Director recently sold AU$9.9m worth of stock

Sonic Healthcare Limited Announces Board Changes

Sonic Healthcare Limited, Annual General Meeting, Nov 17, 2022

Sonic Healthcare Limited, Annual General Meeting, Nov 27, 2022

Insufficient new directors

Recent updates

Sonic in the Running for Healius Imaging Business

New minor risk - Shareholder dilution

Upcoming dividend of AU$0.43 per share

First half dividend increased to AU$0.43

First half 2024 earnings released: EPS: AU$0.43 (vs AU$0.81 in 1H 2023)

Sonic Healthcare Limited to Report First Half, 2024 Results on Mar 20, 2024

Sonic Healthcare Limited (ASX:SHL) signed binding agreements to acquire Pathology Watch Inc. for $130 million.

Finance Director recently sold AU$1.3m worth of stock

Upcoming dividend of AU$0.62 per share at 3.2% yield

Sonic Healthcare Limited Announces Dividend for the Six Months Ended June 30, 2023, Payable on 21 September, 2023

Full year 2023 earnings released: EPS: AU$1.46 (vs AU$3.06 in FY 2022)

Sonic Healthcare Limited to Report Fiscal Year 2023 Results on Aug 17, 2023

Now 20% undervalued after recent price drop

Sonic Healthcare Limited (ASX:SHL) signed an binding agreement to acquire synlab Suisse SA from SYNLAB International GmbH for CHF 150 million.

Upcoming dividend of AU$0.42 per share at 3.1% yield

First half 2023 earnings released

Sonic Healthcare Limited Announces Dividend for the Six Months Ended December 31, 2022, Payable on March 22, 2023

Sonic Healthcare Limited to Report First Half, 2023 Results on Feb 16, 2023

CEO, MD & Executive Director recently sold AU$9.9m worth of stock

Sonic Healthcare Limited Announces Board Changes

Sonic Healthcare Limited, Annual General Meeting, Nov 17, 2022

Sonic Healthcare Limited, Annual General Meeting, Nov 27, 2022

Upcoming dividend of AU$0.60 per share

Full year 2022 earnings released: EPS: AU$3.06 (vs AU$2.76 in FY 2021)

Sonic Healthcare Limited Announces Dividend for the Six Months Ended June 30, 2022, Payable on 21 September, 2022

Insufficient new directors

Upcoming dividend of AU$0.40 per share

Sonic Healthcare Limited (ASX:SHL) announces an Equity Buyback for AUD 500 million worth of its shares.

First half 2022 earnings: EPS in line with expectations, revenues disappoint

Sonic Healthcare Limited Announces Dividend for the Six Months Ended December 31, 2021, Payable on March 23, 2022

Sonic Healthcare Limited (ASX:SHL) acquired ProPath Laboratory, Inc.

Full year 2021 earnings released: EPS AU$2.76 (vs AU$1.11 in FY 2020)

CEO, MD & Executive Director recently sold AU$8.4m worth of stock

Upcoming dividend of AU$0.55 per share

Full year 2021 earnings released: EPS AU$2.76 (vs AU$1.11 in FY 2020)

Sonic Healthcare Limited (ASX:SHL) signed a binding agreement to acquire Canberra Imaging Group.

Rhythm Biosciences Adds Sonic Clinical Services to Colostat Clinical Trial

New 90-day low: AU$31.39

First half 2021 earnings released: EPS AU$1.42 (vs AU$0.54 in 1H 2020)

Revenue beats expectations

Sonic Healthcare Limited to Report First Half, 2021 Results on Feb 18, 2021

Sonic Healthcare Limited to Report Fiscal Year 2021 Results on Aug 18, 2021

Sonic Healthcare Limited Elects Professor Suzanne Crowe as A Director

Sonic Healthcare Limited Do Not Provide Earnings Guidance for the Fiscal Year 2021 Due to COVID-19

Earnings released

New 90-day high - AU$34.66

Sonic Healthcare Limited to Report Fiscal Year 2020 Results on Aug 20, 2020

New 90-day high - AU$33.38

New 90-day high - AU$31.60

CEO 보상 분석

CEO

테뉴어

보상

리더십 팀

평균 재임 기간

평균 연령

이사회 구성원

평균 재임 기간

평균 연령